JPM
63
-4
ABT
57
-5
JNJ
41
2
JNPR
46
3
FMC
31
5
DG
2
-6
HUM
48
6
DE
46
3
PVH
52
-3
AIG
38
-4
COP
56
2
MUR
43
3
HP
38
-2
IBM
54
4
KMX
58
3
EXPE
88
2
DAL
80
-4
IVZ
46
3
HON
65
-2
DTE
50
3
JPM
63
-4
ABT
57
-5
JNJ
41
2
JNPR
46
3
FMC
31
5
DG
2
-6
HUM
48
6
DE
46
3
PVH
52
-3
AIG
38
-4
COP
56
2
MUR
43
3
HP
38
-2
IBM
54
4
KMX
58
3
EXPE
88
2
DAL
80
-4
IVZ
46
3
HON
65
-2
DTE
50
3
Financhill
Back

Alnylam Pharmaceuticals Vs. BridgeBio Pharma Industry Stock Comparison

Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
246.88
Seasonality Move:
10.85%
Buy
51

BBIO
BridgeBio Pharma

Last Price:
23.27
Seasonality Move:
7.7%
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BridgeBio Pharma (BBIO) is a Buy

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $23.04. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $248.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $23.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.64 Sell
Relative Strength Index (14 RSI): 39.68 Sell
Chaikin Money Flow: 997085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (254.01 - 292.55) Sell
Bollinger Bands (100): (248.69 - 281.73) Sell

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 40.41 Sell
Chaikin Money Flow: 1092832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.52 - 25.86) Sell
Bollinger Bands (100): (24.06 - 27.4) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 252.75 Sell
20-day SMA: 267.61 Sell
50-day SMA: 273.13 Sell
200-day SMA: 210.87 Buy
8-day EMA: 250.09 Sell
20-day EMA: 262.36 Sell
50-day EMA: 266.92 Sell
200-day EMA: 230.73 Buy

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.91 Sell
20-day SMA: 24.51 Sell
50-day SMA: 25.12 Sell
200-day SMA: 27.4 Sell
8-day EMA: 23.67 Sell
20-day EMA: 24.39 Sell
50-day EMA: 25.06 Sell
200-day EMA: 26.54 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.35 per share, and a decrease next year of $2.41 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):